<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/48-853.01"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/48-853.01/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_48_853_01">
        <akn:num>48-853.01</akn:num>
        <akn:heading>Definitions.</akn:heading>
<akn:subsection eId="subsec_48-853_01_1">
      <akn:num>(1)</akn:num>
      <akn:content><akn:p>“Administer” shall have the same meaning as provided in § 48-901.02(1).</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_2">
      <akn:num>(2)</akn:num>
      <akn:content><akn:p>“Controlled substance” shall have the same meaning as provided in § 48-901.02(4).</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_3">
      <akn:num>(3)</akn:num>
      <akn:content><akn:p>“Controlled Substances Act” means Unit A of Chapter 9 of this title [§ 48-901.01 et seq.].</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_4">
      <akn:num>(4)</akn:num>
      <akn:content><akn:p>“Covered substance” means all controlled substances included in the schedules set forth in §§ 48-902.06, 48-902.08, 48-902.10, and 48-902.12, in schedules II through V of section 202(c) of Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970, approved October 27, 1970 (84 Stat. 1247; 21 U.S.C. § 812), and any other drug, as specified by rulemaking, that is required to be reported to the Prescription Drug Monitoring Program pursuant to this chapter.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_5">
      <akn:num>(5)</akn:num>
      <akn:content><akn:p>“Department” means the Department of Health.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_6">
      <akn:num>(6)</akn:num>
      <akn:content><akn:p>“Director” means the Director of the Department of Health.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_7">
      <akn:num>(7)</akn:num>
      <akn:content><akn:p>“Dispense” shall have the same meaning as provided in § 48-901.02(7).</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_8">
      <akn:num>(8)</akn:num>
      <akn:content><akn:p>“Dispenser” means a practitioner who dispenses a covered substance to the ultimate user, or his or her agent, but shall not include:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_9">
      <akn:num>(9)</akn:num>
      <akn:content><akn:p>“Drug” means:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_10">
      <akn:num>(10)</akn:num>
      <akn:content><akn:p>“Health occupations board” means a board that, pursuant to § 3-1204.08, licenses and regulates health professionals with the authority to prescribe or dispense covered substances.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_11">
      <akn:num>(11)</akn:num>
      <akn:content><akn:p>“Interoperability” means, with respect to a District of Columbia or state prescription drug monitoring program, the ability of that program to share electronically reported prescription information with another state, district, or territory of the United States’ prescription drug monitoring program or a third party, approved by the Director, that operates interstate prescription drug monitoring exchanges.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_12">
      <akn:num>(12)</akn:num>
      <akn:content><akn:p>“Patient” means the person or animal who is the ultimate user of a controlled substance or other drug required to be submitted under this chapter for whom a lawful prescription is issued or for whom a controlled substance or such other drug is lawfully dispensed.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_13">
      <akn:num>(13)</akn:num>
      <akn:content><akn:p>“Practitioner” shall have the same meaning as provided in § 48-901.02(20).</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_14">
      <akn:num>(14)</akn:num>
      <akn:content><akn:p>“Prescriber” means a practitioner or other authorized person who prescribes a controlled substance or other covered substance in the course of his or her professional practice.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_15">
      <akn:num>(15)</akn:num>
      <akn:content><akn:p>“Prescription drug monitoring program” means a program that collects, manages, analyzes, and provides information regarding covered substances or other drugs required to be submitted under this chapter or a program established by a similar act in another state, district, or territory of the United States.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_16">
      <akn:num>(16)</akn:num>
      <akn:content><akn:p>“Program” means the Prescription Drug Monitoring Program established by § 48-853.02.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-853_01_17">
      <akn:num>(17)</akn:num>
      <akn:content><akn:p>“Ultimate user” shall have the same meaning as provided in § 48-901.02(23).</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
